Formoterol, a new long-acting selective β2-adrenergic receptor agonist: Double-blind comparison with salbutamol and placebo in children with asthma
Authors:
- 1 December 1989
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 84 (6) , 891-895
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Formoterol fumarate, a new β2‐adrenoceptor agonistAllergy, 1989
- Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.Thorax, 1988
- Inhaled Corticosteroids Reduce the Severity of Bronchial Hyperresponsiveness in Asthma, But Oral Theophylline Does NotAmerican Review of Respiratory Disease, 1987
- The bronchodilator effect and pharmacokinetics of theobromine in young patients with asthmaJournal of Allergy and Clinical Immunology, 1985
- The Bronchodilator Effects and Pharmacokinetics of Caffeine in AsthmaNew England Journal of Medicine, 1984
- Anti‐Allergic Activity of Formoterol, a New Beta‐Adrenoceptor Stimulant, and Salbutamol in Human Leukocytes and Human Lung TissueAllergy, 1983
- Effect of aerosol fenoterol on the severity of bronchial hyperreactivity in patients with asthma.Thorax, 1983
- Relationship between bronchial responsiveness to hyperventilation with cold and methacholine in asthmaJournal of Allergy and Clinical Immunology, 1983
- Bronchodilation and inhibition of induced asthma by adrenergic agonistsClinical Pharmacology & Therapeutics, 1981
- Bronchial reactivity to inhaled histamine: a method and clinical surveyClinical & Experimental Allergy, 1977